Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

CRO Market Boom in APAC: China Leads the Charge in Global Clinical Trials

The Asia-Pacific (APAC) Contract Research Organization (CRO) market is experiencing unprecedented growth, with China emerging as the epicenter of this expansion. Recent forecasts project the APAC CRO market to reach $31.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.43% from 2025 to 2030. This surge is driven by increased clinical trial activity, innovation in drug development, and substantial investment from Western pharmaceutical companies and investors.

NoahAI News11/20/2025

Agios Faces Setback in Sickle Cell Disease Trial, Shares Plummet

Agios Pharmaceuticals encountered a significant hurdle in its efforts to expand the use of its drug Pyrukynd (mitapivat) for sickle cell disease (SCD), as phase 3 trial results revealed mixed outcomes. The news sent the company's stock price plummeting by nearly 50% on Wednesday.

NoahAI News11/20/2025

Providence Health System Announces Major Layoffs Amid Financial Pressures

Providence, a prominent West Coast nonprofit health system, has revealed plans for significant workforce reductions across its operations in Washington and Oregon. The cuts come as the organization grapples with ongoing financial challenges, despite recent signs of improvement in its operating margin.

NoahAI News11/20/2025

Tempest Therapeutics Pivots to CAR-T with Factor Bioscience Deal

Tempest Therapeutics, a California-based oncology biotech, has announced a strategic shift towards CAR-T therapy through a significant deal with Factor Bioscience. The all-stock transaction, which is subject to shareholder approval, will see Tempest acquire several CAR-T programs and bring on Factor's CEO to lead the company.

NoahAI News11/20/2025

Former FDA Commissioner Scott Gottlieb Joins UnitedHealth Group's Board Amid Company Overhaul

UnitedHealth Group, the healthcare behemoth, has appointed Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration (FDA), to its board of directors. This strategic move comes as the company grapples with a series of challenges and works to improve its relationship with federal regulators.

NoahAI News11/20/2025

Celltrion Expands US Manufacturing Footprint with $478M Investment

South Korean biosimilar specialist Celltrion has announced plans to invest 700 billion Korean won ($478 million) to upgrade its recently acquired U.S. manufacturing facility in Branchburg, New Jersey. This significant expansion comes just two months after the company purchased the active pharmaceutical ingredient (API) plant from Eli Lilly for approximately $330 million.

NoahAI News11/20/2025

Philips and Edwards Lifesciences Collaborate on AI-Powered Mitral Valve Repair Guidance

Philips and Edwards Lifesciences have announced a groundbreaking collaboration to develop an artificial intelligence-powered tool aimed at revolutionizing mitral valve repair procedures. The new technology, called DeviceGuide, combines ultrasound and X-ray imaging to provide physicians with a real-time 3D visualization of the repair device during transcatheter edge-to-edge repair (TEER) procedures.

NoahAI News11/20/2025

Pharmaceutical Industry News Roundup: Acquisitions, Regulatory Approvals, and Global Competition

Alkermes has escalated its pursuit of Avadel Pharmaceuticals, increasing its offer to $22.50 per share, valuing the company at approximately $2.37 billion. This move comes in response to an unsolicited offer from Lundbeck, which had proposed up to $23 per share. The bidding war centers around Avadel's approved medication for daytime sleepiness in narcolepsy patients. However, analysts have raised concerns about potential commercial challenges in the sleep drug market.

NoahAI News11/20/2025

Distalmotion Raises $150M to Challenge Intuitive Surgical in ASC Market

Distalmotion, a Swiss robotic surgery company, has secured $150 million in funding to accelerate the commercial adoption of its Dexter soft-tissue robotic system in the United States. The investment positions the company to compete directly with industry leader Intuitive Surgical, particularly in the growing ambulatory surgery center (ASC) market.

NoahAI News11/20/2025

Lumexa Imaging Aims for $200M IPO, Highlighting AI's Growing Role in Radiology

Lumexa Imaging, formerly known as US Radiology Specialists, has filed with the Securities and Exchange Commission (SEC) to go public on the Nasdaq under the ticker LMRI. The company, which rebranded in July, is expected to raise up to $200 million in its initial public offering (IPO), according to an analysis by Renaissance Capital.

NoahAI News11/20/2025

General Medicine Launches Comprehensive Digital Health Platform, Aims to Revolutionize Healthcare Access

General Medicine, a new online healthcare marketplace founded by former Amazon employees, has launched with the goal of transforming patient access to medical care. The platform, which connects consumers to a wide range of healthcare services, has already demonstrated significant traction in addressing delayed care and improving healthcare accessibility.

NoahAI News11/20/2025

Aspen Neuroscience Secures $115M Series C for Parkinson's Cell Therapy, Backed by Kite Pharma

Aspen Neuroscience has successfully raised $115 million in a Series C funding round to advance its regenerative cell therapy for Parkinson's disease. The financing, led by OrbiMed, Arch Venture Partners, Frazier Life Sciences, and Revelation Partners, will support the ongoing Phase 1/2 trial of ANPD001 and potential expansion into Phase 3 studies.

NoahAI News11/20/2025

«1...30 31 32...67 »